ub.xmlui.mirage2.page-structure.muninLogoub.xmlui.mirage2.page-structure.openResearchArchiveLogo
    • EnglishEnglish
    • norsknorsk
  • Velg spraakEnglish 
    • EnglishEnglish
    • norsknorsk
  • Administration/UB
View Item 
  •   Home
  • Det helsevitenskapelige fakultet
  • Institutt for helse- og omsorgsfag
  • Artikler, rapporter og annet (helse- og omsorgsfag)
  • View Item
  •   Home
  • Det helsevitenskapelige fakultet
  • Institutt for helse- og omsorgsfag
  • Artikler, rapporter og annet (helse- og omsorgsfag)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabetes: A randomised controlled trial

Permanent link
https://hdl.handle.net/10037/8904
DOI
https://doi.org/10.1136/bmjopen-2015-009116
Thumbnail
View/Open
article.pdf (1.126Mb)
(PDF)
Date
2015-11-13
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Author
Buhse, Susanne; Muhlhauser, Ingrid; Heller, Tabitha; Kuniss, Nadine; Muller, Ulrich; Kasper, Jürgen; Lehmann, Thomas; Lenz, Matthias
Abstract
Objective: To evaluate an informed shared decisionmaking programme (ISDM-P) for people with type 2 diabetes under high fidelity conditions.

Design: Randomised, single-blinded trial with sham control intervention and follow-up of 6 months.

Setting: Single-centre diabetes clinic providing care according to the national disease management programme in Germany.

Participants: 154 people with type 2 diabetes without diagnosis of ischaemic heart disease or stroke. Interventions: The ISDM-P is executed by diabetes educators. Core component is a patient decision aid on the prevention of myocardial infarction supplemented by a 90 min group teaching session. The structurally equivalent control intervention addresses stress issues.

Main outcome measures: Primary outcome was risk comprehension, including realistic expectations about benefits and harms of interventions. It was assessed by a 12-item questionnaire after the teaching session when patients set and prioritise their treatment goals. Key secondary outcome was adherence to treatment goals, operationalised as achievement of individual goals and medication uptake. ISDM-P teaching sessions were video-taped to monitor intervention fidelity.

Results: 72 of 77 ISDM-P and 71 of 77 control patients completed the questionnaire (score 0–12). ISDM-P patients achieved higher levels of risk comprehension, mean score 8.25 vs 2.62, difference 5.63 (95% CI 4.82 to 6.44), and realistic expectations (score 0–6), 4.51 vs 0.85, 3.67 (3.23 to 4.11). More ISDM-P patients wished to take statins, 59.2% vs 30.4%, 28.7% (12.9% to 44.5%); more prioritised blood pressure control, 51.4% vs 25.7%, and fewer intensive glucose control, 33.3% vs 60%, p=0.002. More ISDM-P patients achieved their glycated haemoglobin goals, 95.8% vs 85.7%, 10.1% (0.6% to 19.5%). Achievement of prioritised goals and medication uptake were comparable between groups.

Conclusions: The ISDM-P on preventive measures in type 2 diabetes was effective under high fidelity conditions. Involvement of diabetes educators may facilitate implementation of the informed shared decision-making.

Trial registration number: ISRCTN84636255.

Description
Published version, also available at http://dx.doi.org/10.1136/bmjopen-2015-009116
Publisher
BMJ Publishing Group
Citation
BMJ Open 2015, 5(11)
Metadata
Show full item record
Collections
  • Artikler, rapporter og annet (helse- og omsorgsfag) [842]

Browse

Browse all of MuninCommunities & CollectionsAuthor listTitlesBy Issue DateBrowse this CollectionAuthor listTitlesBy Issue Date
Login

Statistics

View Usage Statistics
UiT

Munin is powered by DSpace

UiT The Arctic University of Norway
The University Library
uit.no/ub - munin@ub.uit.no

Accessibility statement (Norwegian only)